KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Common Equity (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Common Equity data on record, last reported at $12.7 billion in Q4 2025.

  • For Q4 2025, Common Equity rose 1.78% year-over-year to $12.7 billion; the TTM value through Dec 2025 reached $12.7 billion, up 1.78%, while the annual FY2025 figure was $12.7 billion, 1.78% up from the prior year.
  • Common Equity reached $12.7 billion in Q4 2025 per ZBH's latest filing, down from $12.8 billion in the prior quarter.
  • Across five years, Common Equity topped out at $12.8 billion in Q3 2025 and bottomed at $12.0 billion in Q1 2022.
  • Average Common Equity over 5 years is $12.4 billion, with a median of $12.5 billion recorded in 2023.
  • Peak YoY movement for Common Equity: rose 8.07% in 2021, then fell 5.05% in 2022.
  • A 5-year view of Common Equity shows it stood at $12.7 billion in 2021, then decreased by 5.05% to $12.0 billion in 2022, then rose by 3.83% to $12.5 billion in 2023, then fell by 0.1% to $12.5 billion in 2024, then rose by 1.78% to $12.7 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $12.7 billion in Q4 2025, $12.8 billion in Q3 2025, and $12.5 billion in Q2 2025.